The Nigeria Centre for Disease Control (NCDC) reported 574 new infections of COVID-19 Monday.
In a Twitter update via its verified handle, the government agency said there are now 146,928 confirmed cases of the disease caused by the novel coronavirus in Nigeria.
It said a total of 123,009 people have so far been discharged from hospital, while the number of deaths so far is 1,761.
As of Monday, more than 109 million cases of COVID-19 had been reported worldwide, with more than 61.2 million of those cases listed as recovered or resolved in a database maintained by Johns Hopkins University. The global death toll stood at more than 2.4 million.
In Africa, according to the CBC, Zimbabwe has received its first COVID-19 vaccines with the arrival early Monday of an Air Zimbabwe jet carrying 200,000 Sinopharm doses from China. It is one of China’s first shipments of vaccines to Africa, after deliveries to Egypt and Equatorial Guinea.
The first Sinopharm vaccines are a donation from China to the southern African country. President Emmerson Mnanagagwa’s government has purchased an additional 600,000 doses of the Sinopharm vaccine that are expected to arrive early next month, according to state media.
South Africa has reopened its major land borders with neighbouring countries after closing them last month to prevent the spread of COVID-19.
The country, which has seen a cumulative total of nearly 1.5 million cases and 47,000 deaths, has seen a decline in new cases and is set to start vaccinating its front-line health workers with Johnson & Johnson vaccines later this week.
The World Health Organization (WHO) on Monday listed AstraZeneca and Oxford University’s COVID-19 vaccine for emergency use, widening access to the relatively inexpensive shot in the developing world.
A WHO statement said it had approved the vaccine as produced by AstraZeneca-SKBio and the Serum Institute of India.
Doses of AstraZeneca’s vaccine make up the lion’s share of doses in the COVAX coronavirus vaccine sharing scheme, with more than 330 million doses of the shot due to begin being rolled out to poorer countries from the end of February.